Bone Biologics Corporation

BBLG

Financials

10-QQ3 ended 09/30/2610/26/26 10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/02/26 10-QQ3 ended 09/30/2511/14/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report09/16/26 8-KCurrent report07/23/26 8-KCurrent report07/16/26 8-KCurrent report07/09/26

Prospectuses and Registrations

424B3Prospectus07/24/26 S-3Shelf registration07/17/26 424B5Prospectus supplement03/13/26 S-8Registration of securities for employees09/26/25 S-3/AShelf registration (amended)08/29/25

Proxies

DEF 14ADefinitive proxy08/28/26 PRE 14APreliminary proxy08/18/26 DEFA14AAdditional proxy materials07/20/26 DEF 14ADefinitive proxy07/02/26 DEFA14AAdditional proxy materials07/02/26

Ownership

Form 4Insider transaction09/30/26 Form 4Insider transaction09/30/26 Form 4Insider transaction09/30/26 Form 4Insider transaction09/30/26 Form 4Insider transaction01/21/26

Other

25-NSERemoval from listing10/13/26 EFFECTRequest for effectiveness07/24/26 ARSAnnual report to shareholders07/02/26 EFFECTRequest for effectiveness09/02/25 CORRESPCorrespondence with the SEC08/29/25